Lv19
28 积分 2024-02-26 加入
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance
1小时前
待确认
Augmenting antitumor efficacy of Th17-derived Th1 cells through IFN-γ-induced type I interferon response network via IRF7
6小时前
已完结
Strategies for non-viral vectors targeting organs beyond the liver
1天前
已完结
In vivo production of CAR-T cells using virus-mimetic fusogenic nanovesicles
2天前
已完结
Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA
3天前
已完结
128 Development of an M1-polarized, non-viral chimeric antigen receptor macrophage (CAR-M) platform for cancer immunotherapy
5天前
已完结
Non-viral therapeutic cell engineering with the Sleeping Beauty transposon system
5天前
已完结
In Vitro Engineering Chimeric Antigen Receptor Macrophages and T Cells by Lipid Nanoparticle-Mediated mRNA Delivery
7天前
已完结
In situ engineering of mRNA-CAR T cells using spleen-targeted ionizable lipid nanoparticles to eliminate cancer cells
11天前
已完结
mRNA-Laden Lipid-Nanoparticle-Enabled in Situ CAR-Macrophage Engineering for the Eradication of Multidrug-Resistant Bacteria in a Sepsis Mouse Model
11天前
已完结
皖公网安备34019202002308
